Kay J J van der Hoogt, Robert-Jan Schipper, Leon C Ter Beek, Ronni Wessels, Hedda J van der Hulst, Arjan Te Boekhorst, Regina G H Beets-Tan, Ritse M Mann
{"title":"Influence of gadolinium-based contrast agent (GBCA) on the diffusion weightings of breast lesions: an intra-patient analysis.","authors":"Kay J J van der Hoogt, Robert-Jan Schipper, Leon C Ter Beek, Ronni Wessels, Hedda J van der Hulst, Arjan Te Boekhorst, Regina G H Beets-Tan, Ritse M Mann","doi":"10.1007/s10334-026-01381-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the influence of gadolinium-based contrast agent (GBCA) administration on breast lesions' signal intensities on diffusion-weighted images and its derived ADC maps acquired 2 min after GBCA administration.</p><p><strong>Materials and methods: </strong>An intra-patient analysis was performed. 110 lesions > 5 mm in 93 patients, visible on screening and pre-operative MRI scans at 1.5 T and 3.0 T, were included. Pre-contrast and post-contrast DWI were acquired with single-shot spin-echo echo-planar imaging (SSh-SE-EPI) with b0, b50, b150, and b800 diffusion weightings. 2D regions of interest were drawn. Each b value was separately analyzed regarding signal intensities on DWI. Furthermore, ADC values were compared based on the pairs b0-b800 and b150-b800. The comparison between pre- and post-contrast DWIs was investigated within and between different groups (overall, malignant/benign, and at 1.5/3.0 T). The Wilcoxon-signed rank test and independent Student T test were used when appropriate. P < 0.01 was considered as statistically significant.</p><p><strong>Results: </strong>Overall, and for malignant and benign lesions separately, a significant change after contrast administration in signal intensity was observed at each specific b value, irrespective of the use of 1.5 T or 3.0 T. The effect of contrast administration was overall notably different when comparing b0 (+ 9.4%) vs. b800 (+ 11.8%), but this was not observed between b150 (11.4%) and b800 (11.8%) (P = 0.10). In malignant lesions, specifically, all b value pairs, except b0-b50, showed significant differences in GBCA effects. This translates into a pre-post-contrast difference of the ADC value of 3.2% (P = 0.02) when based on b0-b800 and 0.9% (P = 0.11) when using b150-800.</p><p><strong>Conclusions: </strong>There is a limited, but significant effect of contrast administration on DW signal intensities measured 2 min after contrast administration. This effect is not the same for each b value. Signal change is stronger for high than for low b values, which leads to a larger change in measured ADC values after contrast administration when b0 and b50 are incorporated in the calculation. As a consequence, ADC calculations obtained from b150-b800 seem to be more robust than those obtained from b0-b800.</p>","PeriodicalId":18067,"journal":{"name":"Magnetic Resonance Materials in Physics, Biology and Medicine","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magnetic Resonance Materials in Physics, Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10334-026-01381-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To investigate the influence of gadolinium-based contrast agent (GBCA) administration on breast lesions' signal intensities on diffusion-weighted images and its derived ADC maps acquired 2 min after GBCA administration.
Materials and methods: An intra-patient analysis was performed. 110 lesions > 5 mm in 93 patients, visible on screening and pre-operative MRI scans at 1.5 T and 3.0 T, were included. Pre-contrast and post-contrast DWI were acquired with single-shot spin-echo echo-planar imaging (SSh-SE-EPI) with b0, b50, b150, and b800 diffusion weightings. 2D regions of interest were drawn. Each b value was separately analyzed regarding signal intensities on DWI. Furthermore, ADC values were compared based on the pairs b0-b800 and b150-b800. The comparison between pre- and post-contrast DWIs was investigated within and between different groups (overall, malignant/benign, and at 1.5/3.0 T). The Wilcoxon-signed rank test and independent Student T test were used when appropriate. P < 0.01 was considered as statistically significant.
Results: Overall, and for malignant and benign lesions separately, a significant change after contrast administration in signal intensity was observed at each specific b value, irrespective of the use of 1.5 T or 3.0 T. The effect of contrast administration was overall notably different when comparing b0 (+ 9.4%) vs. b800 (+ 11.8%), but this was not observed between b150 (11.4%) and b800 (11.8%) (P = 0.10). In malignant lesions, specifically, all b value pairs, except b0-b50, showed significant differences in GBCA effects. This translates into a pre-post-contrast difference of the ADC value of 3.2% (P = 0.02) when based on b0-b800 and 0.9% (P = 0.11) when using b150-800.
Conclusions: There is a limited, but significant effect of contrast administration on DW signal intensities measured 2 min after contrast administration. This effect is not the same for each b value. Signal change is stronger for high than for low b values, which leads to a larger change in measured ADC values after contrast administration when b0 and b50 are incorporated in the calculation. As a consequence, ADC calculations obtained from b150-b800 seem to be more robust than those obtained from b0-b800.
期刊介绍:
MAGMA is a multidisciplinary international journal devoted to the publication of articles on all aspects of magnetic resonance techniques and their applications in medicine and biology. MAGMA currently publishes research papers, reviews, letters to the editor, and commentaries, six times a year. The subject areas covered by MAGMA include:
advances in materials, hardware and software in magnetic resonance technology,
new developments and results in research and practical applications of magnetic resonance imaging and spectroscopy related to biology and medicine,
study of animal models and intact cells using magnetic resonance,
reports of clinical trials on humans and clinical validation of magnetic resonance protocols.